The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition

Breast Cancer. 2023 Oct 7. doi: 10.1007/s12282-023-01505-x. Online ahead of print.ABSTRACTThe Japanese Breast Cancer Society (JBCS) Clinical Practice Guidelines for systemic treatment of breast cancer were updated to the 2022 edition through a process started in 2018. The updated guidelines consist of 12 background questions (BQs), 33 clinical questions (CQs), and 20 future research questions (FRQs). Multiple outcomes including efficacy and safety were selected in each CQ, and then quantitative and qualitative systematic reviews were conducted to determine the strength of evidence and strength of recommendation, which was finally determined through a voting process among designated committee members. Here, we describe eight selected CQs as important updates from the previous guidelines, including novel practice-changing updates, and recommendations based on evidence that has emerged specifically from Japanese clinical trials.PMID:37804479 | DOI:10.1007/s12282-023-01505-x

Source: Breast Cancer - October 7, 2023 Category: Cancer & Oncology Authors: Mitsuo Terada Aki Ito Yuichiro Kikawa Kei Koizumi Yoichi Naito Tatsunori Shimoi Mikiya Ishihara Takashi Yamanaka Yukinori Ozaki Fumikata Hara Rikiya Nakamura Masaya Hattori Minoru Miyashita Naoto Kondo Tetsuhiro Yoshinami Masahiro Takada Koji Matsumoto Ka Source Type: research